Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Peter Schiff Says Strategy’s Bitcoin Sales Mark End of Saylor’s Never-Sell Era

Peter Schiff Says Strategy’s Bitcoin Sales Mark End of Saylor’s Never-Sell Era

CoineditionCoinedition2026/06/30 06:45
By:Coinedition

Strategy’s newly announced Bitcoin Monetization Program has reignited debate over the company’s long-term Bitcoin strategy after longtime Bitcoin critic Peter Schiff argued the move marks a major shift from accumulation to selling.

Notably, the discussion gathered pace after Coin Edition challenged Schiff’s interpretation, suggesting the framework could be viewed as balance-sheet management rather than a retreat from Strategy’s Bitcoin-focused approach. The exchange comes only days after Schiff publicly argued that Strategy should consider selling Bitcoin to create shareholder value.

Schiff criticized Strategy’s new program after the company disclosed it could sell portions of its Bitcoin holdings under specific circumstances. According to the framework, Bitcoin sales may be used to raise $1.25 billion for a U.S. dollar reserve, meet preferred dividend payments and debt interest obligations, and help fund up to $2 billion in planned share buybacks.

Responding to the announcement, Schiff wrote that “MSTR is now a Bitcoin seller” and claimed the company had shifted from being Bitcoin’s largest corporate buyer toward becoming its largest seller.

He later added that Michael Saylor’s long-standing objective had been to never sell Bitcoin.

“It is a failure,” Schiff wrote. “Saylor’s goal was to never sell Bitcoin. Now he has no choice but to sell it.”

Schiff also questioned how Bitcoin would react if its largest corporate holder eventually became a consistent source of supply for the market.

Related:

Coin Edition challenged Schiff’s argument by asking why monetizing Bitcoin should automatically be viewed as a failure if the proceeds strengthen Strategy’s balance sheet and support shareholder obligations.

Even so, the publication also pointed to Schiff’s earlier comments from last week, when he suggested Strategy should sell some of its Bitcoin holdings to repurchase MSTR shares as the stock traded at a discount to the value of its Bitcoin per share.

That prompted another question from Coin Edition asking what principle distinguishes selling Bitcoin to unlock shareholder value from selling Bitcoin under a formal treasury management program.

Schiff maintained that the difference lies in Saylor’s original commitment to permanent accumulation rather than the mechanics of the transactions themselves.

Related:

Meanwhile, the debate also prompted questions from market participants over whether Strategy had already become Bitcoin’s largest seller.

Grok responded that the answer is no, noting that Strategy remains the largest corporate Bitcoin holder with roughly 847,000 BTC accumulated over several years.

(adsbygoogle = window.adsbygoogle || []).push({});

According to Grok, the newly introduced Bitcoin Monetization Program authorizes targeted and limited Bitcoin sales tied to treasury management objectives rather than broad liquidation. It also noted that Strategy’s previous Bitcoin sales have been minimal, including a sale of 32 BTC earlier this year.

For now, the discussion centers less on the size of any potential sales and more on what the policy represents. Supporters view the program as a treasury tool designed to improve financial flexibility, while critics such as Schiff argue it signals a departure from Strategy’s long-held commitment to continuous Bitcoin accumulation.

div#ce-iframe-ads div#frame { margin: auto; text-align: center; }
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Novo Nordisk (NVO.US) renamed to "Novo" for a fresh start—Can multi-line breakthroughs dispel the shadow over its stock price?

Danish pharmaceutical company Novo Nordisk (NVO.US) has launched a comprehensive rebranding centered around the shorter name "Novo." The company will use "Novo" in daily brand promotion, but its legal name will remain Novo Nordisk A/S.

智通财经2026/09/14 11:56
Novo Nordisk (NVO.US) renamed to "Novo" for a fresh start—Can multi-line breakthroughs dispel the shadow over its stock price?

High interest rates are not the "end" of US stocks? Is profitability the real key?

JPMorgan believes that profit growth is the key factor determining the resilience of U.S. stock valuations. Data since 1950 shows an "inverted U-shaped" relationship between the 10-year U.S. Treasury yield and S&P 500 valuations. Based on current profit levels, yields would need to reach about 5%-6% to significantly compress valuations. As long as profit growth remains above 15%, there is still room for valuations to be re-rated. If the yield curve steepens in a bear market, cyclical sectors such as energy and financials will benefit more; if it flattens, technology stocks will have a relative advantage.

华尔街见闻2026/09/14 10:41

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky